Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function

BACKGROUND: Lung cancer is one of the most lethal cancers worldwide. Cisplatin, a widely used anti‐lung cancer drug, has been limited in clinical application due to its drug resistance. Medicines targeting mitochondrial electron transport chain (ETC) complexes may be effective candidates for cisplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Jingyao, Zhu, Dongshan, Chen, Mengmeng, Wang, Taiwei, Gao, Yan, Liu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108040/
https://www.ncbi.nlm.nih.gov/pubmed/35429141
http://dx.doi.org/10.1111/1759-7714.14425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108040/
https://www.ncbi.nlm.nih.gov/pubmed/35429141
http://dx.doi.org/10.1111/1759-7714.14425

Ejemplares similares